HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 445580Erstellt: 27. Oktober 2026
Doconexent
DHA-FA · HY-17031-25g · Docosahexaenoic Acids · Docosahexaenoic acid(mix) · Docosa-2,4,6,8,10,12-hexaenoic acid · (2E,4E,6E,8E,10E,12E)-docosa-2,4,6,8,10,12-hexaenoic acid
https://huagongshe.com/de/chemical/445580
Identifikatoren & physikalische Daten
| CAS No. | 25167-62-8 |
|---|
| Summenformel | C22H32O2 |
|---|
| Durchschnittliche Molmasse | 328,5 g/mol |
|---|
| Monoisotopische Masse | 328,24023026 g/mol |
|---|
| SMILES | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O |
|---|
| InChIKey | MBMBGCFOFBJSGT-KUBAVDMBSA-N |
|---|
| PubChem CID | 445580 |
|---|
| ChEMBL | CHEMBL367149 |
|---|
| ChEBI | CHEBI:28125 |
|---|
| EC No. | 612-950-9 |
|---|
| DTXSID | DTXSID5040465 |
|---|
Chemische & physikalische Eigenschaften
| XLogP | 6,2 |
|---|
| Polarare Oberfläche (TPSA) | 37,3 |
|---|
| H-Brücken-Donoren | 1 |
|---|
| H-Brücken-Akzeptoren | 2 |
|---|
| Frei drehbare Bindungen | 14 |
|---|
| Schwere Atome | 24 |
|---|
| Formalladung | 0 |
|---|
| Komplexität | 462 |
|---|
| Arzneimittel | Pharmaceuticals -> Listed in ZINC15 |
|---|
| Lipide | Lipids -> Unambiguous LipidsFatty Acyls [FA] -> Fatty Acids and Conjugates [FA01] -> Unsaturated fatty acids [FA0103] |
|---|
| Kosmetika | AntistaticSkin conditioning |
|---|
| SpringerMaterials Properties | Chemical diffusion |
|---|
| Physical Description | Liquid |
|---|
| Collision Cross Section | 187.9 Ų [M-H]- [CCS Type: DTBuffer gas: N2Sample Type: Human bronchoalveolar lavage fluid (BALF)Dataset: Unambiguous Lipids]184.62 Ų [M+H]+ [CCS Type: DTMethod: stepped-field]183.5 Ų [M+H]+ |
|---|
| Kosmetik-Inhaltsstoffe Funktionen | ANTISTATICSKIN CONDITIONING |
|---|
| InChI | InChI=1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h10-21H,2-9H2,1H3,(H,23,24)/b11-10+,13-12+,15-14+,17-16+,19-18+,21-20+ |
|---|
| InChIKey | DVSZKTAMJJTWFG-SKCDLICFSA-N |
|---|
| SMILES | C(O)(=O)/C=C/C=C/C=C/C=C/C=C/C=C/CCCCCCCCC |
|---|
| LogP (Verteilungskoeffizient) | 7.780 (est) |
|---|
Sicherheit & Vorschriften
| GHS-Einstufung | This chemical does not meet GHS hazard criteria for 98.2% (56 of 57) of all reports.Not ClassifiedAggregated GHS information provided per 57 reports by companies from 2 notifications to the ECHA C&L Inventory. |
|---|
| Regulatorische Informationen | Docosahexaenoic acid: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.4,7,10,13,16,19-Docosahexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right. |
|---|
| Hazard Classes and Categories | Not Classified |
|---|
| Alarmwort | Warnung |
|---|
| Gefahrenhinweise | Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H302 |
|---|
Anwendungen & Verwendung
Beschreibung
Docosahexaenoic acid (DHA) is an omega-3 fatty acid found in cold-water, fatty fish, such as salmon.It is also found in fish oil supplements, along with eicosapentaenoic acid (EPA). Vegetarian sources of DHA come from seaweed. Docosahexaenoic acid (DHA) is essential for the growth and functional development of the brain in infants. DHA is also required for maintenance of normal brain function in adults. The inclusion of plentiful DHA in the diet improves learning ability, whereas deficiencies of DHA are associated with deficits in learning. DHA is taken up by the brain in preference to other fatty acids. The turnover of DHA in the brain is very fast, more so than is generally realized. The visual acuity of healthy, full-term, formula-fed infants is increased when their formula includes DHA[1].